Applied

Type

Modification

Confidence

88%

Created

Apr 19, 2026

Evidence

1 source

Rationale

The stale ESVS citation was replaced with the superseding ESVS 2024 guideline ESVS in both instances where it appeared, as the newer guideline covers the same claims (AAA prevalence and screening/surveillance recommendations). No other content changes were warranted; the existing text remains accurate and well-structured.

Content Changes

Aneurysmal disease spans abdominal ([[abdominal aortic aneurysm (AAA)]]), thoracic ([[TAA]]), thoracoabdominal ([[TAAA]]), and peripheral arterial beds [@esc2014] and remains a leading cause of sudden vascular death due to rupture. AAA prevalence in men ≥65 years is approximately 1.5–4.5% [@esvs2024-editors][@esvs2024] and lower in women, who have higher rupture risk at smaller diameters [@svs2018]. Thoracic aneurysms are less common but carry high lethality, particularly in connective tissue disorders (Marfan, Loeys–Dietz, vascular Ehlers–Danlos) [@esc2014]. Peripheral aneurysms (popliteal, femoral, visceral, renal) often coexist with AAA [@dawson1997]. Population screening of older men reduces AAA-related mortality and emergent repairs, and contemporary guidelines define who to screen and how to surveil detected AAAs [@mass2002] [@svs2018] [@esc2014] [@esvs2024-editors].[@esvs2024]. For peripheral arterial disease management, see [[PAD]].